Lu Hongbo Insider Trading Activity

Average Profitability
19.77%
Insider Buys Quantity
6
Insider Buys Sum
$12.74M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Lu Hongbo

According to the SEC Form 4 filings, Lu Hongbo, being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2970 shares for $228,334,
    over all time since 2024-03-18, has bought 3000 shares for $82,990, and sold 2970 shares for $228,334.

Biography of Lu Hongbo

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $3,725,058480
Sells
 $228,334120

Comparison of Insiders on Amount of Buys and Sells

2026-05-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
2,970
0.0021%
$76.88$228,334-2.4%
2026-03-31PurchaseZenas BioPharma, Inc.
ZBIO
director
75,000
0.1719%
$20.00$1.5M+38.62%
2026-03-31PurchaseZenas BioPharma, Inc.
ZBIO
director
3,768
0.008%
$18.63$70,198+38.62%
2026-03-31PurchaseZenas BioPharma, Inc.
ZBIO
director
78,768
0.1799%
$19.93$1.57M+38.62%
2026-02-11PurchaseZenas BioPharma, Inc.
ZBIO
director
25,985
0.06%
$22.50$584,663+12.33%
2025-10-07PurchaseZenas BioPharma, Inc.
ZBIO
director
263,160
0.5695%
$19.00$5M+26.38%
2024-09-13PurchaseZenas BioPharma, Inc.
ZBIO
director
58,823
0.2079%
$17.00$999,991-43.29%
2024-03-20PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$27.50$27,500-21.24%
2024-03-19PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$28.00$28,000-19.9%
2024-03-18PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$27.49$27,490-20.81%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.